Skip to main content
DARE logo

Daré Bioscience, Inc. (DARE)

DARENASDAQHealthcareBiotechnology

$0.41Today:+$0.00 (+0.44%)1Y −73.10%

As of Nov 20, 2026 close

Market cap
$6.73M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$3.78
Volume (live)
-
Avg. volume (3M)
172.89K

Daré Bioscience (DARE) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Daré Bioscience reported total assets of $32.47M and total liabilities of $29.63M. Shareholders' equity was $2.84M. Total debt stood at $2.66M against $24.71M in cash and short-term investments, a net cash position of $22.06M. That puts debt-to-equity at 0.93.

Daré Bioscience Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Daré Bioscience, Inc. (DARE) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Dec 2020Dec 2019Mar 2019Dec 2017
Current Assets
Cash and Cash Equivalents24.7115.7015.7010.4834.6751.6751.674.674.786.817.56
Cash & Short-Term Investments24.7115.7015.7010.4834.6751.6751.674.674.786.817.56
Accounts Receivable0.570.230.230.951.701.151.150.460.560.030.28
Inventory0.000.00-0.000.000.00-0.000.00-402.690.31
Other Current Assets0.072.522.756.126.672.482.481.851.110.400.51
Total Current Assets27.0618.4518.4517.5443.0455.3055.306.986.447.248.35
Non-Current Assets
Property, Plant & Equipment (Net)4.402.542.541.980.520.240.240.280.550.010.00
Long-Term Investments0.000.00-0.340.000.00-0.000.000.000.00
Goodwill0.000.00-0.000.000.00-0.000.000.005.19
Other Non-Current Assets1.011.111.110.600.260.270.130.290.450.580.72
Total Non-Current Assets5.413.653.653.740.790.510.510.571.000.595.91
Total Assets32.4722.1022.1021.2843.8355.8155.817.557.447.8314.26
Current Liabilities
Accounts Payable1.201.461.463.392.032.102.101.021.080.460.31
Short-Term Debt2.100.55-0.470.400.27-0.710.410.000.00
Current Portion of Long-Term Debt0.01-0.00--------
Accrued Liabilities0.53-3.041.8110.89-3.143.36---
Deferred Revenue19.6516.5616.5613.7418.3010.5410.541.562.020.000.00
Other Current Liabilities0.013.040.002.8910.893.14-1.002.100.630.66
Total Current Liabilities23.6921.6121.6120.4831.6216.0516.057.665.611.090.97
Non-Current Liabilities
Long-Term Debt0.560.754.750.940.090.00-0.040.390.000.00
Other Non-Current Liabilities5.394.755.753.911.000.001.000.001.000.000.00
Total Non-Current Liabilities5.956.506.505.851.091.001.001.041.390.010.00
Total Liabilities29.6328.1128.1126.3332.7117.0517.058.707.001.100.97
Stockholders' Equity
Common Stock0.000.000.000.000.010.010.010.000.000.000.00
Retained Earnings-188.69-175.29-175.29-171.24-141.07-110.13-110.13-71.43-44.02-28.97-12.23
Accumulated Other Comprehensive Income-0.42-0.43-0.43-0.36-0.35-0.15-0.15-0.09-0.10-0.10-0.02
Additional Paid-in Capital191.95169.71169.71166.55152.53149.03149.0370.3744.5635.7925.54
Shares Outstanding14.50-8.708.337.07-7.00----
Total Stockholders' Equity2.84-6.01-6.01-5.0511.1138.7538.75-1.150.446.7313.29
Total Liabilities & Equity32.4722.1022.1021.2843.8355.8155.817.557.447.8314.26

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Daré Bioscience Balance Sheet

How much debt does Daré Bioscience have?

Daré Bioscience had total debt of $2.66M as of Dec 31, 2025, against $24.71M in cash and short-term investments. Its debt-to-equity ratio was 0.93. Total debt was $1.30M a year earlier.

What are Daré Bioscience's total assets?

Daré Bioscience reported total assets of $32.47M as of Dec 31, 2025, up 46.9% from $22.10M a year earlier. Total liabilities were $29.63M.

What is Daré Bioscience's shareholders' equity?

Daré Bioscience's shareholders' equity was $2.84M as of Dec 31, 2025, or about $0.20 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition